Your Daily Roundup for October 13th
Let us know your thoughts in the comments!
Good morning. As the COVID-19 pandemic takes a toll on life in America, our team at Future Majority is tracking the latest updates:
Another clinical trial has been paused:
Johnson & Johnson was forced to halt their late-stage clinical trial of a potential COVID-19 vaccine due to an “unexplained illness” in one of the trial volunteers. The pharmaceutical company had just begun its Phase 3 trial, and although it was behind other companies, its vaccine does not need to be frozen and has the potential to only require one dose instead of two.
This is the second trial in the U.S. that was stopped in its tracks due to adverse events after two volunteers in the AstraZeneca trial suffered serious illnesses.
President Trump again falsely claimed he is “immune” to COVID-19:
At his first campaign rally since his COVID-19 diagnosis, President Trump told supporters -- many of whom were maskless and not socially distanced -- that he felt “so powerful” and was immune to the virus. There is no scientific evidence to suggest that those who recover from COVID-19 are immune. Just yesterday, scientists confirmed that a 25-year-old man in Nevada was reinfected with different strains of the virus.
New battleground state polling shows a closer race than nationally, but Biden leads:
Polling in several key battleground states show former Vice President Joe Biden ahead of President Trump, though the margin is closer than in national polling.
NY Times/Siena found Biden up 10 points over Trump in Wisconsin, 8 points ahead in Michigan, while Reuters/Ipsos found Biden ahead 7 points in Pennsylvania.
Your Daily Round Up for February 28thGood afternoon. Here are the latest news and updates that our team at Future Majority is tracking. Another Saturday, another
#TrumpSlump Stresses Global MarketsWall Street Journal Reports: U.S. Stocks Fall on Fresh Trade Tensions U.S. stocks fall as a result of Trump's tweet saying he Infrastructure
Your Daily Roundup for January 22ndPresident Biden has issued several executive actions to address COVID-19: After a year of a disjointed federal response under